Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings
1. MDT posted stronger-than-expected Q1 earnings, achieving $8.58 billion in sales. 2. Company raised its FY 2026 sales guidance to $35.72-$35.82 billion. 3. Board appointments announced, including two independent directors effective immediately. 4. MDT's organic revenue growth remains confident at 5% for FY 2026.